- 1. Copper binding with N-truncated amyloid-β peptides and links with Alzheimer's disease
- 2. Advanced analysis towards establishing the geometry of Cu-binding sites of N-truncated amyloid-β and refining precise structural parameters
- 3. Experimental methods
- 4. CuII-binding ligands in N-truncated Aβ4–8/12/16 peptides from XAS
- 5. Cu reduction and CuI-binding ligands in N-truncated Aβ4–8/12/16 peptides
- 6. CuII oxidation in N-truncated Aβ4–8/12/16 peptides
- 7. Supporting information
- 8. Conclusions
- Supporting information
- References
- 1. Copper binding with N-truncated amyloid-β peptides and links with Alzheimer's disease
- 2. Advanced analysis towards establishing the geometry of Cu-binding sites of N-truncated amyloid-β and refining precise structural parameters
- 3. Experimental methods
- 4. CuII-binding ligands in N-truncated Aβ4–8/12/16 peptides from XAS
- 5. Cu reduction and CuI-binding ligands in N-truncated Aβ4–8/12/16 peptides
- 6. CuII oxidation in N-truncated Aβ4–8/12/16 peptides
- 7. Supporting information
- 8. Conclusions
- Supporting information
- References
research papers
Nanostructure and dynamics of N-truncated copper amyloid-β from advanced X-ray absorption fine structure
aSchool of Physics, University of Melbourne, Australia, bThe Florey Institute of Neuroscience and Mental Health, University of Melbourne, Australia, and cSchool of Chemistry, University of Melbourne, Australia
*Correspondence e-mail: chantler@unimelb.edu.au
This article is part of a collection of articles from the IUCr 2023 Congress in Melbourne, Australia, and commemorates the 75th anniversary of the IUCr.
An β (Cu:Aβ) samples under near-physiological conditions. N-truncated Cu:Aβ peptide complexes contribute to oxidative stress and neurotoxicity in Alzheimer's patients' brains. However, the redox properties of copper in different Aβ peptide sequences are inconsistent. Therefore, the geometry of binding sites for the copper binding in Aβ4–8/12/16 was determined using novel advanced extended X-ray absorption fine structure (EXAFS) analysis. This enables these to perform redox cycles in a manner that might produce toxicity in human brains. Fluorescence measurements were corrected for systematic errors including defective-pixel data, monochromator glitches and dispersion of pixel spectra. Experimental uncertainties at each data point were measured explicitly from the point-wise variance of corrected pixel measurements. The copper-binding environments of Aβ4–8/12/16 were precisely determined by fitting measurements with propagated experimental uncertainties, advanced analysis and hypothesis testing, providing a mechanism to pursue many similarly complex questions in bioscience. The low-temperature measurements here determine that CuII is bound to the first amino acids in the high-affinity amino-terminal copper and nickel (ATCUN) binding motif with an oxygen in a tetragonal pyramid geometry in the Aβ4–8/12/16 Room-temperature electrochemical-cell measurements observe metal reduction in the Aβ4–16 peptide. Robust investigations of provide structural details of CuII binding with a very different bis-His motif and a water oxygen in a quasi-tetrahedral geometry. Oxidized measurements of Aβ4–12/16 imply that both CuII and CuIII are accommodated in an ATCUN-like binding site. Hypotheses for these CuI, CuII and CuIII geometries were proven and disproven using the novel data and statistical analysis including F tests. Structural parameters were determined with an accuracy some tenfold better than literature claims of past work. A new protocol was also developed using data analysis for monitoring radiation damage. This gives a template for advanced analysis of complex biosystems.
electrochemical cell was used to collect high-quality measurements of N-truncated Cu:amyloid-Keywords: N-truncated copper amyloid-β peptides; X-ray absorption fine structure; radiation damage; nanostructure; XAS electrochemical cells; binding motifs; redox cycles.
1. Copper binding with N-truncated amyloid-β and links with Alzheimer's disease
Alzheimer's disease (AD) is a common progressive brain disorder that develops into irreversible dementia (Holtzman et al., 2011). AD is characterized by association with the existence of amyloid plaques in the human brain, which mainly consist of amyloid-β (Aβ) Aggregation of amyloid cascades combined with metal-ion oxidation lead to toxic functions, including generation of reactive oxygen species (ROS) (Hureau, 2012). The toxicity relating to ROS is produced by transition metal ions such as Cu, Zn and Fe bound to the Aβ peptide (Smith et al., 2000; Barnham et al., 2004; Ganguly et al., 2017; Drew, 2017). Furthermore, N- and C-terminal heterogeneity was reported in early protein studies of amyloid plaque cores (APCs) in AD brains (Masters et al., 1985b) and in vitro experiments (Pike et al., 1995). The majority of APCs consist of Aβ sequences starting at position 4, the phenylalanine (Phe4) residue (Masters et al., 1985a,b). Interestingly, metal-bound N-truncated Aβ create a higher neurotoxicity (McLean et al., 1999; Cheignon et al., 2018) than full-length Aβ in patients' brains (Dietrich et al., 2018; Dunys et al., 2018; Cabrera et al., 2018). A better understanding of the redox behaviour of Cu-bound N-truncated and the toxicity arising from radicals is crucial for pathogenesis.
Different coordination spheres of Cu-binding geometry in Aβ and in the affinity of the metal have been reported (Streltsov et al., 2008; Faller & Hureau, 2009; Summers et al., 2019; Abelein et al., 2022). CuII binding may involve three N and one O (Huang et al., 1999; Wang & Hanson, 1995). The three N coordinations are associated with three His residues; the fourth O coordination could arise from water, carboxyl or hydroxyl side chains, or a phosphate buffer in Aβ1–42/28 (Curtain et al., 2001; Drew et al., 2009a).
N-truncated Aβ4–y may accommodate a high-affinity amino-terminal copper and nickel (ATCUN; H2N-X-X-His) motif in their structure due to the phenylalanine, arginine and histidine (F4R5H6) residues at the end of the peptide (Harford & Sarkar, 1997; Mital et al., 2015; Bossak-Ahmad et al., 2019; Esmieu et al., 2021). The motif accommodates a chelate ring including terminal amine-Phe4, deprotonated backbone from Arg5 and His6, and His6-imidazole nitrogen donor atoms (Harford & Sarkar, 1997; Sóvágó & Ősz, 2006). Similar involvement of nitrogens in CuII binding was identified (Shearer et al., 1967) in serum albumin. ATCUN-chelated binding coordination through tetradentate ligands has also been considered (Camerman et al., 1976). Hureau et al. (2011) proposed high-affinity CuII chelating coordination geometries and binding of a water molecule in the apical position for CuIIGHK and CuIIDAHK complexes using X-ray analysis. Mital et al. (2015) suggested an involvement of CuII with the ATCUN motif in N-truncated Aβ4–16 peptides.
Karr et al. (2005) suggested that CuII binding has no involvement with Tyr10 using (EPR) spectra, whereas Stellato et al. (2006) suggested Cu binding to the oxygen atom in the Tyr10 hydroxyl group from X-ray absorption near-edge structure (XANES) and X-ray absorption fine structure (XAFS) analysis. Mital et al. (2015) performed the pH dependance of the CuII binding in N-truncated Aβ and reported a pH value of about 10 for Tyr10. Streltsov et al. (2008) suggested CuII binding in the peptide across His6/13/14, and with Asp1 or Glu11 residues in the full-length Karr et al. (2005) claimed that CuII binding is involved only with His6/13 using different-length Aβ and EPR spectroscopy. Involvement of Tyr10 and Glu11 residues in Cu binding has been a controversial and much disputed subject.
Cu binding with the ATCUN followed by a bis-His motif is illustrated for protein structures such as transmembrane Cu transport protein (CTR1) (Pushie et al., 2015). CTR1 and the Hst5 antimicrobial peptide (AMP) separate the bis-His motif from the ATCUN motif compared with N-truncated Aβ sequences (Tay et al., 2009).
Best et al. (2016) introduced a flow cell to the standard fluorescence experimental setup to obtain measurements of any biological compound such as organometals, proteins and catalysts with minimal radiation damage.
The involvement of nitrogens and oxygens for the coordination CuI in the Aβ was suggested (Himes et al., 2007, 2008; Raffa et al., 2007; Shearer & Szalai, 2008; Hureau et al., 2009; Balland & Hureau, 2010; Furlan et al., 2010). Pushie et al. (2015) proposed quasi-tetrahedral four-coordinated CuI binding involving two imidazole N from bis-His, one S and one backbone carbonyl O. They claimed that their proposed model is more probable than the two-coordinated bis-His CuI structures. Streltsov et al. (2018) suggested a quasi-tetrahedral geometry for CuI binding in N-truncated Aβ4–16 using extended (EXAFS) analysis. The reported binding geometries are controversial, and there is no general agreement on CuI coordination geometry in Therefore, it is important to investigate Cu-binding coordination in different-length Aβ4–y peptides.
2. Advanced analysis towards establishing the geometry of Cu-binding sites of N-truncated amyloid-β and refining precise structural parameters
In this article, we introduce advanced data and statistical analysis to a complex biosystem to determine molecular parameters, nanostructure and local environment to a much higher accuracy than otherwise possible with standard approaches. et al., 1994; Filipponi & Di Cicco, 1995; Filipponi, 1995). A major issue is the propagation of uncertainty from experimental systematics in (Chantler et al., 1999, 2012; Chantler, 2009; Schalken & Chantler, 2018; Trevorah et al., 2019).
is an ideal element-selective tool to investigate many biological samples, organometals and metal provides high-resolution nanostructural information, and is suitable for sensitive samples. Current uses `goodness of fit' measures, but without incorporating uncertainties derived from the standard deviations of experimental measurements (O'DayThis enables us to perform much more rigorous assessments and indeed carry out quantitative hypothesis testing of alternate bonding and novel bonding sites.
Herein, we establish the geometry of binding sites for key copper binding in N-truncated Aβ4–y at low temperatures, and separately under near-physiological conditions. Aβ4–8, Aβ4–12 and Aβ4–16 (F4RHDS8GYEV12HHQK16) sequences of N-truncated Aβ were investigated, based on their enhanced solubility relative to the full-length wild-type Aβ1/4–42 at low and room temperature. Aβ4–16 accommodates His6, His13 and His14 in its structure, whereas the shorter only accommodate His6 in their structures. The shortest peptide does not include the tyrosine and glutamine residues in its sequence, allowing an investigation of the involvement of the absent residues in copper binding. Streltsov et al. (2018) performed preliminary analysis for identifying the geometry of Cu-binding sites in Cu-bound N-truncated Aβ4–y. In that study, conventional analysis used interpolated data points to generate oscillations. In this work, data were analysed avoiding any interpolation and loss of information, to get more insightful results for hypothesis testing. Interpolations of experimental data on to a regularly spaced grid in k space would distort experimental values, information content, point density and experimental uncertainties (Schalken & Chantler, 2018). Furthermore, in this work we avoid guessing a constant data uncertainty, as in conventional analysis, and instead measure the self-consistency and data uncertainty by the reproducibility of data. More importantly, we can then use this to distinguish hypotheses with quantitative statistical measures including F tests.
We developed novel in situ electrochemical control (XAS-EC) (Streltsov et al., 2018) to explore the redox properties of different-length CuII-bound N-truncated Aβ Here, we determine the ability of Cu-bound N-truncated Aβ4–8/12/16 to perform redox cycles in a manner that might produce ROS, facilitating oxidative damage under physiological conditions. To be explicit, XAS-EC is a novel development of this and our recent work, but this novel experimental methodology is not directly related to the X-ray extended range technique (Chantler et al., 2001; Sier et al., 2020; Ekanayake et al., 2021; Chantler, 2022) or formally to the hybrid methodology (Schalken & Chantler, 2018; John et al., 2023; Best & Chantler, 2022). Rather, key developments herein lie in data treatment and analysis.
underThis work also details the quality control of Aβ measurements. As a core starting point, we propagated experimental uncertainties of measurements from point-wise variance of experimental measurements and experimental systematics. Systematic corrections are incorporated in uncertainty calculations to determine better uncertainties in fitted parameters. Error analysis based on the measured experimental uncertainties corresponding to experimental systematics and noise is limited in data analysis, and the absence of this can result in unreliable structural insight.
Here, we also determine the precise values of nanostructural bond lengths and thermal parameters from novel advanced
analysis.An absolute determination of a structure for hypothesis testing was carried out using eFEFFit (Smale et al., 2006; Schalken & Chantler, 2018), analysis, FEFF6 (Zabinsky et al., 1995) and FEFF8 (Ankudinov et al., 2003) for propagated uncertainties. We consider, for the first time, quantitative spectroscopic analysis of the coordination chemistry of CuII, CuI and CuIII. Our initial investigations of the structural parameters of Cu-binding sites in Aβ4–y (Streltsov et al., 2018) did not include propagated uncertainties in the refinements. Estimated uncertainties were incorporated in the goodness-of-fit measurements. These uncertainties could then be under- or over-estimated due to contributions of noise, which can lead to limitations in hypothesis testing in structural refinement.
In this study, we also develop a new approach to monitor radiation damage that incorporates fits of individual scans of the Aβ4–y The average of the repeated scans of Cu-bound N-truncated Aβ4–y was refined in our initial investigations of the geometry of Cu-binding sites in the Aβ4–y (Streltsov et al., 2018). If the photodamage is not properly identified, analysis will be skewed, and therefore, the refined structural parameter will provide misleading information (Ekanayake et al., 2024; Streltsov et al., 2018).
3. Experimental methods
et al., 2018). The development of our experimental setup enables accurate measurements of Cu-bound Aβ samples at ambient temperatures. The quality of spectra can be monitored and controlled during the data collection. We herein addressed systematic issues including defective-pixel exclusion, dead-time correction, deglitching, data truncation, detector inefficiency, data flattening and radiation damage, developed in detail by Ekanayake et al. (2024). Characteristic features of CuI:Aβ1–16 were investigated by measuring XANES spectra with the potential stepped from −0.25 to −0.65 V (0.05 V, −0.05 V, −0.45 V, −0.65 V). The reduction of CuII:Aβ4–16 to CuI:Aβ4–16 was investigated by obtaining XANES-EC spectra at different reducing potentials from −0.15 to −0.45 V (−0.15 V, −0.25 V, −0.35 V, −0.45 V). The generation of oxidized products of CuII:Aβ4–8/16/12 was investigated at an oxidative potential of 0.95–1.35 V.
at low temperatures and XAS-EC at room temperature were performed at the beamline of the Australian Synchrotron (Streltsov4. CuII-binding ligands in N-truncated Aβ4–8/12/16 from XAS
4.1. Identification of CuII-binding ligands from XANES
XANES spectra of N-truncated CuII:Aβ4–8/12/16 and CuII:Aβ1–16 were investigated to compare apparent nanostructure prior to detailed analysis. The XANES spectra of the low-temperature of CuII:Aβ4–8/12/16 are virtually identical [Fig. 1(a)], suggesting identical CuII-binding geometry for the three especially compared with the CuII:Aβ1–16 spectrum.
CuII:Aβ4–8 has neither Tyr10, Glu11 nor histidines (His13 or His14) in its structure. The consistency of spectra between all the CuII:Aβ4–8/12/16 datasets suggests the same CuII-binding ligands for all three Therefore, it must be dominated by the CuII:Aβ4–8 peptides.
The spectra of CuII:Aβ1–16 appear equivalent to previously measured spectra under similar conditions (Streltsov et al., 2008), which suggested that the CuII-binding site of Aβ1–16 involved either carboxylate O (Tyr10, Glu11) or histidine N atom (His13 or His14) coordination, but not the first three residues. The CuII:Aβ1–16 spectrum is noticeably different from CuII:Aβ4–8/12/16, suggesting a specific and different CuII -binding form. The Aβ1–16 CuII site has previously been shown to be highly pleomorphic and suggested to involve from one to all three histidine residues: H6H13H14 (Karr et al., 2005; Drew et al., 2009b; Streltsov et al., 2008; Yu et al., 2008; Cheignon et al., 2017). The current XANES data neither prove nor indicate any pleomorphism.
These identical characteristics of XANES CuII:Aβ4–8/12/16 spectra justify the suggestion of some common site for the CuII-binding geometry (Camerman et al., 1976; Hureau et al., 2011; Mital et al., 2015; Bossak-Ahmad et al., 2019) and prove the non-involvement of residues beyond the eighth peptide.
A very weak pre-edge peak at 8978 eV for CuII:Aβ1–16 and a very weak feature at 8979 eV (Streltsov et al., 2008, 2018; Pratesi et al., 2012) for CuII:Aβ4–16 [Fig. 1(b)] have been linked to the 1s–3d electric dipole forbidden transition of CuII. A higher pre-edge intensity is usually observed for CuII:Aβ1–16 with the increase of dihedral angles between ligands (Sano et al., 1992). In the ATCUN-type CuII:DAHK peptide, the N-terminal fragment of the human serum albumin has a consistent behaviour (Hureau et al., 2011) in the pre-edge features at 8987 and 8988 eV, relating to the 1s–4s transition or 1s–4p transitions. This significant variation of intensity is probably related to the geometry of the ligands (Strange et al., 1990; Streltsov et al., 2008). It can also be affected by the spectral resolution (divergence, bandwidth, slit size, polarization).
The identical XANES spectra confirmed that neither Tyr10, Glu11 nor histidines (His13 or His14) are bound to the Cu. In these two proposed cases, the CuII:Aβ4–8 structure would be very different from that of CuII:Aβ4–12/16. Thus, the CuII-binding site of all Aβ4–8/12/16 appears to not involve either carboxylate O (Tyr10, Glu11) or histidine N atom (His13 or His14) coordination, and is instead formed by the first three residues. This limits the range of any possible proposed pleomorphism.
Streltsov et al. (2018) initially suggested the geometry by generating XANES and an interpolated grid using standard analysis software. Important features in the pre-edge region, point density, and valuable information about the coordination geometry at different temperatures and under different experimental conditions are distorted when experimental data are interpolated into a regularly spaced grid. In this study, data processing yields more insightful results for hypothesis testing. The improvement of spectra and data processing primarily confirms this conclusion based on XANES, but a clear quantitative statistical conclusion is required from the following data section.
4.2. of the CuII-binding site in Aβ4–8/12/16 from advanced analysis of low-temperature EXAFS
Fig. 2 presents the data collected for the 4–y with repeated measurements. The data are self-similar, both in k and R space, and the resulting model fits all data well, within uncertainty, and with parameters that are consistent within uncertainty. Again, this argues for a common model, in a much more conclusive manner than the XANES evidence, albeit, at this stage, qualitative.
The spectroscopy appears very similar for each of the three CuIIAβ4–8/12/16 peptide fragments. The fits of the model to individual in k and R space (Fig. 2), and the resulting structural parameters (Table 1), are in good agreement within the uncertainty. The absolute uncertainties for the refined structural parameters use the propagated systematic data uncertainties.
‡Isotropic thermal parameters for the first- and second-shell N and O atoms were fixed to 0.001 and 0.00105 Å2, respectively, in consonance with general fits and physically meaningful ranges, after considering several refinements of each scan. This row contains the fitted thermal parameter for the third and outer shells. § is the thermal isotropic parameter for the water molecule. |
The independent fitting parameters were: an energy offset of the δE0), the amplitude reduction factor ( S02), two independent thermal parameters for the axial water and for the third- and outer-shell neighbours (), and ten independent radial adjustment distances. Eight restraint functions were also included to maintain reasonable parameters for S02, and five bond-length estimates. Additionally, two thermal parameters were fixed for the nearest-neighbour nitrogens (0.001 Å2) and for the second shell (0.00105 Å2).
(Incorporation of multiple scattering and mean-square disorder for multiple scattering paths is essential (O'Day et al., 1994; Ressler et al., 1999). Multiple scattering contributions with greater than 10% relative predicted amplitude with triple scattering paths with four legs were included in the refinements. In general, the values of the shift in radial position of a peptide unit were tied to that of its nearest neighbour, and the corresponding for that atom and in turn for relevant scattering paths including that atom was tied to that of the free parameters.
Consider for a moment the use of standard k range presented, and with no simultaneously fitted range in R space. Then the traditional formula defines and , and the usual metric using the so-called `Nyquist criterion' yields a negative goodness of fit, which is clearly invalid and impossible (Schalken & Chantler, 2018; Trevorah et al., 2020). Ergo, some might argue that the data do not permit a fit of even a single independent free parameter. If the R range was simultaneously fit over, for example, 1 Å < R < 4 Å (a fraught process), then the perception would be that only parameters could be defined, with `', by that definition of thousands, quite untenable in valid statistics. Complex arguments in the literature have suggested that the correct Nindp may be larger or smaller by one or two, but this, in any case, yields a negative goodness-of-fit metric and remains nonsensical. The solution, of course, is to use the actual number of independent data points, Nidp, which in these individual datasets is of order 200 or so, and is of course better in other datasets or if simultaneously fitting multiple datasets. Let us reiterate that it is perfectly possible to define 15 near-independent parameters to very high accuracy if data uncertainties are measured individually and used in a valid goodness-of-fit metric.
analysis, especially with the restrictedA second concern is that this structure is very complex and has many local atoms, many bond lengths and angles, and hence many more parameters than the 15 fitted. Conventional k range. On this detail, we follow the modelling of Streltsov et al. (2008), which models the quantum system for in a very similar manner to that used in crystallography and X-ray diffraction – that is, with known a priori information, constraints and restraints from biological molecular models. This is how it has become possible to gain insight into so many critical parameters.
analysis would fit the few nearest-neighbour values and assume that multiple legged paths and distant scattering shells were insignificant – though in fact both are significant, especially in the lowerThe goodness-of-fit measure was weighted least squares including the estimated uncertainties of the experimental data, as contrasted with past conventional post facto constant uncertainty estimate and unweighted fit. The fitting was performed with k0 weights of χ(k) data in k space with 3.0 Å−1 ≤ k ≤ 12.0/10.0/11.0 Å−1 for CuII:Aβ4–16/12/8, respectively. Note that, unlike most analysis, because we propagate uncertainty to χ, fits in kn are or should be identical irrespective of n = 0, 1, 2, 3, with identical output and uncertainties. That is, the scaling of data and the scaling of uncertainty must be and are isomorphic. The eFEFFit script for the model is given in the supporting information.
analysis on most systems, which uses aA three-dimensional CuII:Aβ4–y structural model based on the reported density functional theory (DFT) for the CuII:Aβ4–16 structure (Mital et al., 2015) was initially constructed for fitting the The first shell of CuII coordination in this ATCUN-binding site for CuII:Aβ4–y has an arrangement of four nitrogen ligands in equatorial positions, including the phenylalanine amino group N(Phe4), two deprotonated from the first two peptide bonds – N(Arg5) and N(His6), and an N atom of the imidazole side chain of the histidine residue ND1(His6). Here, we introduce a new model including an additional fifth coordination oxygen along the apical Jahn–Teller distortion axis, similar to the structure of the CuII:DAHK peptide complex determined by single-crystal X-ray diffraction (Hureau et al., 2011). This new model gives the best fit. Fig. 3 shows the CuII with the water molecule in the ATCUN-binding site for CuII:Aβ4–y peptides.
Variance and noise between datasets are primarily due to low-temperature noise and ice defects in regions of individual spectra and pixels. The consistency of the spectra between all of the CuII:Aβ4–8/12/16 datasets suggests that the CuII coordination geometry does not change noticeably for the three and that therefore it must be dominated by the CuII:Aβ4–8 peptide. This in turn suggests that the CuII-binding geometry of CuII:Aβ4–8/12/16 is dominated by the high-affinity ATCUN site, which appears unaffected by residues beyond y = 8. The detailed fits confirm this hypothesis (Table 1).
Remarkable similarity of the parameters of the ATCUN fitting model across II binding, again in a stronger proof than that of the plotted-fit consistency.
confirms the non-involvement of Tyr10 or Glu11 in CuRepeated measurements do not show the loss of amplitude and blurring of spectral features expected from radiation damage. If radiation damage permitted alternate binding (trigonal binding has been reported), we would expect to see developing pleomorphism and blurring of features, but these are not seen in the data.
S02 is theoretically expected to represent the many-body relaxation of all the electrons in the absorbing atom to the hole in the core level, and should therefore theoretically be less than or equal to unity within uncertainty. This amplitude-reduction factor ( S02) has been claimed to be about 0.9 for a copper compound (Poiarkova & Rehr, 1999). Similarly, it has been stated that S02 should be 0.9 ± 0.1 for a good fit of a sample (Levina et al., 2005; Ellis & Freeman, 1995). We obtain within 1–3 standard deviations for all at low temperature. S02 was a free parameter refined in the fits. In this analysis, the result is fully consistent with conventional literature expectations. Predictions of S02 are highly model- and energy-calibration dependent, and do not currently reflect advanced theoretical expectations.
Experimentally, S02 is highly correlated with the of nearest neighbours (N). This then confirms very well the value of the N, which is 100% correlated with any incorrect value of S02. We can therefore say clearly that N is accurate to better than 10%. Whilst Ni is an integer for each shell and is not a free parameter for a given model, the strong evidence for the apical water site confirms the very strong evidence for the given coordination numbers.
The energy (calibration) offset relative to the monochromator setting δE is less than 10 eV, and robust around 3.5–4.3 eV. If the energy axis was significantly in error (e.g. too high), this correlates with an effective apparent decrease in S02 or N, and with an error in the fitted shell or path radii rj.
The shell or path radii ri have uncertainties, especially for the inner shell, remarkably below 1 pm for individual scans, even though the data are relatively short range and noisy. These values are largely consistent with different scans and within uncertainty. This is a direct consequence of reasonable and propagated uncertainties.
We report both χ2, relevant for hypothesis and model testing and F tests, and , which is the usual marker for goodness of fit. None of these are scaled or rescaled. A good statistician might be concerned that is a bit less than unity, indeed varying for an individual fit from 0.69 to 0.23. In fact, these values support our uncertainty estimates to within a factor of 2. If the uncertainty estimate is the dominant issue, then the uncertainties in the table of parameters would be reduced by , i.e. by 20% or 50% in the most significant case, and hence would be even smaller than stated. We provide the model-dependent δχ2 for discussion of model and hypothesis testing.
4.3. Multiple data fitting in eFEFFIT for consistent datasets
Fig. 4 shows the estimated uncertainties propagated from raw data to χ versus k for individual scans and then for a merged dataset. We can fit the merged datasets, or we can simultaneously fit multiple datasets with the same model. Streltsov et al. (2018) fitted unweighted merged datasets for all Here, we use weighted simultaneous fits of multiple datasets, to prove both the consistency with the individual fits and the consistency between the peptide fragments.
The eFEFFit package previously used only one scan for structural refinements. We developed the feffit2.f and iff-feffit2.f code, subroutines in eFEFFit, so that multiple scans can be used to refine structures. Three CuII:Aβ4–8/16 scans and repeated CuII:Aβ4–8/12/16 scans were simultaneously fitted to the CuII-binding model after confirming the consistency from eFEFFit individual refinements. The weighted average of repeated scans was used for each peptide. Table 2 provides the fitted results. The first and second columns give the multiple-scan fit results of CuII:Aβ4–8/16 while the third column provides the multiple-scan fit results of CuII:Aβ4–8/12/16.
|
It is encouraging to compare multiple-dataset refined parameters with individual refined parameters to control the quality of new development in eFEFFIT. The multiple-dataset refined values (Table 2) are consistent with the individual refined measurements (Table 1). The fits of the model to multiple scans in k space (Fig. 5) remain in good agreement with the experimental measurements. The multiple data involves more experimental data points, enabling an increase in individual parameters for a better fit. Therefore, uncertainties are generally reduced, and accuracy is increased where the datasets are consistent. In particular, the final pooled is unity, confirming strongly the estimated uncertainties and the propagation through the process of analysis, together with the use of valid goodness-of-fit metrics.
4.4. CuII:Aβ discussion of data and literature concerns
The earliest tris-His site with tyrosine and perhaps oxygen (Stellato et al., 2006; Minicozzi et al., 2008; Morante, 2008) for Cu:Aβ1–16, and observe that deleting the first suggests bis-His with tyrosine, N-terminal and oxygen for Cu:Aβ5–23. These reported estimates on path lengths have uncertainties of ± 0.01 Å, σ2 ≃ 0.002 (1) Å2. The energy offset was relatively large, δE0 = 11–14 eV.
studies at room temperature suggest aShearer & Szalai (2008) and Hureau et al. (2009) investigated Cu:Aβ1–16 at room temperature and concluded a bis-His Asp1 amine N backbone carbonyl square-planar coordination, with bis-His and 2 N/O distorted square-planar geometry. Shearer et al. (2010) investigated Cu:Aβ1–42 at room temperature and concluded a tris-His N with one additional unidentified N/O in a square-planar geometry. None of these suggested pleomorphism.
Streltsov et al. (2008) suggested tris-His binding and two Asp1/Glu11 carboxylate oxygen binding with one axial water in a distorted octahedral coordination for Cu:Aβ1–16 at low temperature (20 K). An impressive 10–13 repeat scans of each species were performed, taking 40 min each. Radiative damage was observed. Radii were accurate to ± 0.007–0.01 Å, and σ2 of the first shell was 0.0020 (5) Å2. They provided strong evidence that Tyr10 was not involved in these bindings. All these scans investigated Cu:Aβ1–16 and not the common truncated Cu:Aβ4–y.
Streltsov et al. (2018) directly investigated Cu:Aβ4–y at low temperature (10 K). Their δE0 was perhaps relatively large (6.33 eV) and their radii had large uncertainty (0.14 Å, 0.04 Å), with a σ2 of 0.0035 (4) Å2, but some of the raw data were in common with the current work. Streltsov et al. (2018) suggested a tetragonal pyramid geometry for CuII binding in N-truncated Aβ4–y using analysis, though based on an estimation of uncertainty as a constant (ε) in kxχ space. Conversely, our study finds a δE0 of 3.6 eV; radii with uncertainty 0.006 Å, 0.01 Å; and a σ2 of 0.0089 (4) Å2. Distortions in S02 and ΔE0 can be seen in the earlier results, which are addressed in the current analysis. The ordering of the nearest-neighbour bonds changes, for the two closest contacts, although some of these were indistinguishable within uncertainty in the more standard analysis. For the same radius, element and analysis does not distinguish between which nitrogen is the closer contact but it can identify their separation. This current work shows the apical water to be more tightly bound, though both studies show a high variance (σ2) on that bond distance, even at low temperature, due to the relatively weak potential binding and probably structural variation. That study could model only 10, 8 or 6 `independent' parameters, whereas the current advanced analysis can measure 15 or so, while still improving the accuracy of each independent bond length, often by a factor of 14, by propagating the uncertainties with a valid goodness-of-fit criterion. Using and propagating estimated uncertainties dramatically aids fitting experimental data.
4.5. CuII:Aβ questions of pleomorphism
Pleomorphism is known to exist in Aβ fragments, Aβ1–42 and e.g. CuII:Aβ1–42. Which is to say that the different fragments, including under different pH etc., fold or bind in more than one way, and hence one will see a mixture of different molecular shapes, contacts and bindings to the central Cu atom. This will then blur X-ray diffraction maps and modelling, or perhaps reveal multiple components from a principal components analysis (PCA) and related techniques. Simple of the molecule, by contrast, may be unobservable and indistinguishable by since the local bond distances, bond angles and related structure may be identical. Similarly, structures that only begin to differ at the fourth coordination shell, or at angles at far distances, may also be indistinguishable. We and others have proven that third shells, and three-leg and four-leg paths are explicitly observable with high-quality data. Our current study primarily fits the inner two shells, so is quite plausible. The critical questions here are whether CuII:Aβ4–8 is one structure (monomorphic), even in solution, at least in near-physiological pH, and similarly CuII:Aβ4–12 and CuII:Aβ4–16; whether the binding site and structure are consistent and self-similar within the region of the first three shells, representing the same binding structure; and how to measure this in the data and analysis.
Summers et al. (2019) investigated CuII:Aβ1–42 at low temperature (10 K) and different pH values (especially 6.1, 7.4 and 9.0), and concluded that the N of nearest neighbours varies from ∼4 at low pH to ∼5 at high pH. They confirmed that the local binding is sensitive to and suggested that only one His bond is present below a pH of 7.4 and that perhaps two are bound above that pH. They also made a careful summary of conclusions from experiments on various CuII:Aβ peptide fragments, using a variety of experimental techniques. This literature, as discussed in Section 1, predicts any of: square planar, distorted square planar, tetragonal, square pyramidal and distorted octahedral nearest-neighbour geometries. However, we expect different fragments to have different binding, and we have proven this above.
Summers et al. (2019) raised four major concerns about investigating Cu: or Zn:Aβ fragments, and specifically Aβ1–16. One concern was whether the binding is of the monomer, or if aggregation had occurred and the target structure was an oligomer. Some authors have claimed that Aβ1–16 does not aggregate. With analysis, the local structure can be determined irrespective of this concern. Shearer et al. (2010) considered explicitly oligomeric Cu:Aβ1–42. It remains unclear what impact this might have had on the structure.
Summers et al. (2019) concluded that pleomorphism exists across pH and buffer choice, and especially from pH 6.1 through to 9.0 and at near-physiological 7.4. They also claim that the structure at near-physiological pH is not a mixture or PCA combination of reference structures at low and high pH. Pleomorphism has been suggested for Cu:Aβ1–16 in studies using other techniques from 2009 through to 2014. Interestingly, Summers et al. (2019) also collected high-energy resolution fluorescence detection (HERFD-XAS) data, which should have higher resolution and may require fitting with different theory. Indeed, their HERFD-XAS structures show higher resolution, and also show different structure from their scans. They conclude that the structure at near-physiological pH (7.4) may be a different dominant coordination than those from low and high pH, but is probably multiple pleomorphic. Their second concern would then be interpreted as the following: most studies, especially using assume a single binding structure without pleomorphism, whereas they look for an `averaged structure' but by fitting a single structure. This is isomorphic to fitting a single structure.
Summers et al. (2019) concluded that, given an assumption of pleomorphism, solving for multiple structural components using standard is difficult or infeasible; and that structural information will be heavily limited. Furthermore, solving for a single component will either be invalid or yield high or a distorted structure, from the heterogeneity of the local environment. We find no such evidence, either in our data or theirs (see especially the discussion on CuI below). They also appear to have presented no experimental evidence in favour of this pleomorphism or the multiple-component composition.
4.6. CuII:Aβ questions of data information content for analysis, and radiation damage
A third concern raised by Summers et al. (2019) is the `reluctance to dismiss Tyr10 in coordination', though, indeed, for Cu:Aβ1–16, Streltsov et al. (2008) had explicitly investigated this with structural tests. Similarly, here, we also investigate this for Cu:Aβ4–y, and the results are conclusive.
Summers et al. (2019) stated that analysis has very heavy (stringent) limits on the determination of backscattered distances, including the number of scattering shells, and the ability to identify or quantify nearby radii, due to low-resolution R-space data, in turn caused by limited or even broad k data. They claimed that it is infeasible to determine δri < 0.12 Å for data only fitting or collected from k ≃ 0 up to k = 13 Å−1, considering a Nyquist-like prescription commonly used in the community and attributed incorrectly to Nyquist. Similarly, they claimed that results reported in earlier Aβ fragment studies by analysis of related peptide samples (Stellato et al., 2006; Minicozzi et al., 2008; Streltsov et al., 2008) were invalid due to these resolution limitations, that is, minimum separations of radii of nearby shells should have been 0.16 Å and 0.13 Å, respectively. These papers conclude that separations of 0.020 (8) Å are meaningful, for example, for CuII:Aβ1–16 and CuII:Aβ1–42 (Streltsov et al., 2008). Summers et al. (2019) claimed that fitting of multiple backscatterers at similar distances separated by less than 0.12 Å to 0.16 Å would return an artificially inflated due to false (phase) cancellation of the respective photoelectron waves. This limitation issue is commonly cited but not discussed in analysis with Fourier-transform data. We do not directly address the earlier Aβ fragment experiments on this topic because uncertainties were not defined or propagated to the final fits, so the uncertainties might be underestimated. We agree that components and parameters, including shell radii, which are highly correlated (i.e. very similar radii), are therefore challenging or sometimes impossible to define.
However, our experiments and this article defined and propagated uncertainties, so that the parameter uncertainties are at least robust. In particular, maths and information content has never required a full separation of a wave component to define it; rather, it requires sufficient data accuracy and spacing to separate components, which are of course always overlapping. Notably, Summers et al. (2019) give reference examples where they have reported features at smaller separations than the false Nyquist assumption.
Closely spaced shell radii can be distinguished with high-accuracy experimental data and well defined experimental uncertainties and noise. If the uncertainties are too large or the parameters are not independent then the resolution of the shells is weaker (Trevorah et al., 2020). Our fitted determined shell radii are given to high accuracy from ±0.04 down to ±0.0001 Å. In particular, we determine meaningful shell separations for CuII:Aβ4–y down to 0.018 (6) Å, far below a naive 0.16 Å limit. Our results prove that N is not skewed. An integer error of N would represent a 20% error of backscatterer cancellation, which is not observed. We compute 10% or greater contributions of multiple scatterings in the fits. This supports a number of the previous experimental findings, including Streltsov et al. (2018), on this point, though more research will be valuable.
Summers et al. (2019) claimed that the range 0.0015 Å2 ≤ σ2 ≤ 0.0080 Å2 is the physically plausible range for the isotropic thermal parameter, that values above this range are unreasonable as the structure from each wave would be hard to extract from software, and that values below this range are unreasonable because there must always be some inherent vibration. Of course, this statement is temperature dependent. It is also pleomorphism dependent (see below). They comment that many of the previous fits have σ2 ≃ 0.008–0.009 Å2, and that therefore the associated fit components are highly dampened (broadened) and therefore probably unrealistic. We agree that extreme values of σ2 are a useful marker of possible problems with the analysis or the quality of the data.
Conversely, our k (Fig. 2) and refined consistent and physical innermost-shell σ2 values in the range of 0.001 Å2 ≤ σ2 ≤ 0.0089 Å2 within the uncertainties. Trevorah et al. (2020) conducted more critical analysis to observe significant features and peaks in spectra with reported higher σ2 and proved the possibility of a low value of σ2 within the refined errors. Our best fitted values are comparable within the given uncertainty with the refined values for CuIIAβ4–y (Streltsov et al., 2018), CuIIAβ1–16/42 (Streltsov et al., 2008) and the CuII imidazole system (Binsted et al., 1992), and with the values obtained for the similar systems (Poiarkova & Rehr, 1999; Dimakis & Bunker, 2002).
measurements with propagated uncertainties accurately fitted including peaks at higherSummers et al. (2019) concluded that CuII coordination in monomeric Aβ1–42 resulted in multiple conformations in a range of pH solutions (i.e. it is intrinsically pleomorphic and pH dependent). The latter is certainly true and shown by their data. However, they provide no evidence for pleomorphism from their data or fits and do not attempt to fit multiple components. If the pleomorphism was strong, and shell radii from different geometries were overlapping, then we would expect a high σ2 from the blurring of shells. Conversely, we find strong evidence for data fitting for a single species under our experimental conditions. Goodness-of-fits χ2 and reflect the validity of the fitted model, where
and
where σ(ki) is the associated propagated uncertainty in k space. More concerningly, Summers et al. (2019) used a fit error function defined as
This error function forces the data to highly weight the high-k data points, where the amplitude and signature are dominated by the single-closest-shell radius, so that the others are indeed poorly defined. And it does not weight the range of the data equally. Thirdly, σ(ki) is not measured and is set to a somewhat arbitrary constant for all k, even after scaling by k3. More importantly, this is not an appropriate goodness-of-fit function, whether for least-squares analysis or for Bayesian analysis. It is unfortunate that this error function was used, and it would be interesting and instructive to repeat their experiment with defined uncertainty and propagation, and to use hypothesis testing for any pleomorphism that may or may not be present.
There was a large and excellent discussion by Summers et al. (2019) of the prevalence of radiation damage, including in their results. We discuss this in detail in another paper (Ekanayake et al., 2024) and prove that we have no observable radiation damage.
4.7. Discussion of CuII results in N-truncated Aβ4–8/12/16 peptides
There are different types of CuII coordination proposed or believed in Aβx–y We have demonstrated that ATCUN-type binding coordination is dominant for CuII binding in Aβ4–y Huang et al. (1999), Curtain et al. (2001) and Drew et al. (2009a) proposed three N and one O for CuII coordination, while Streltsov et al. (2008) introduced three N, three O and axial water. Faller & Hureau (2009) discussed two N and one O for CuII coordination in Aβ Our model suggests four N and a water molecule in an axial direction for CuII coordination in CuII binding in Aβ4–y strongly arguing against these earlier models. However, our suggestions confirm the binding ligands suggested by Streltsov et al. (2018) for CuII:Aβ4–12/16 with more reliable answers obtained from the advanced analysis.
Structural refinements without the water molecule confirmed improvement of the suggested CuII-binding model. The significance is supported with the statistical F test by generating calculated F2, 31 = 4.33, which is greater than the tabulated criterion of F2, 31, 0.05 = 3.30 at the common significance level of α = 5%. The refined distances of the CuII ion for the equatorial nitrogen atoms and apical water were obtained ranging from 1.831 (8) to 2.05 (1) and 2.13 (2) Å, respectively. The findings of the current study are consistent within the uncertainties with those of reported values for the CuII:DAHK complex in crystallography (Hureau et al., 2011). Similarly, Camerman et al. (1976) illustrated the CuII chelating of ATCUN. They discussed a square-planar-binding arrangement with Cu–N distances and a weak O interaction with Cu–O. These results are also consistent with ours. These comparisons suggest the possibility of CuII ATCUN binding with an axial water in tetragonal pyramid geometry for N-truncated Aβ peptides.
These results corroborate those observed in earlier studies by Mital et al. (2015), as they discussed the CuII binding with the ATCUN motif. However, Mital et al. (2015) stated that three N atoms and one O atom are involved in the binding. Similarly, Huang et al. (1999) and Curtain et al. (2001) discussed the CuII binding with three N atoms and an O atom in Our studies contradict these earlier findings, proving a new CuII binding with four N and one axial water in the fifth position. The controversial discussion on the involvement of tyrosine in CuII binding is addressed from our findings. Stellato et al. (2006), Mital et al. (2015) and Wiloch et al. (2016) have argued that Tyr10 has been associated with the Cu binding; however, our findings have evidently disproved that argument, certainly for Aβ4–y, justifying Karr et al. (2005) and Streltsov et al. (2018) on this point.
Streltsov et al. (2018) proved that a significant number of independent parameters can be fitted in spectra, even when the number of data points and the k range are limited, and that complex bio-systems can be modelled and investigated using a priori peptide and biological and chemical constraints. Herein, in this article and in this section, we have investigated a series of hypotheses for low-T CuII results in N-truncated Aβ These hypotheses are summarized in the following paragraph (`confirmed' means `proven').
(1) The bonding (model spectra and structure in quantitative detail) of sequential CuII:Aβ4–8 datasets is self-similar, and separately the bonding of sequential CuII:Aβ4–16 datasets is self-similar – confirmed, showing no broadening due to radiation damage (which normally lowers the and hence induces pleomorphism). (2) The thermal parameters for bond lengths in all (each) peptide fragments studied are consistent with a single molecular structure – confirmed, showing no observable (measurable) pleomorphism. (3) The structures refined in all cases for each peptide fragment scan show no observable multiple component or multiple species – confirmed, no pleomorphism. (4) The detailed structural fits of each scan and of all seven scans in a multiple fitting with uncertainty weights are self-similar for CuII:Aβ4–8/12/16 datasets – confirmed, proving that the bonding in these three fragments is self-similar at least out to the third bonding shell, noting that there are significant data contributions from at least the fourth coordination shell and from four-leg paths in the data and in the fit; this also proves quantitatively the absence of Tyr10 and Glu11 binding in these structures. Clearly these fragments cannot bind histidines (His13 or His14) either, yet the binding is strong. (5) The detailed consistency of all fits proves that the structure is bound in an ATCUN-binding site, as previously suggested – confirmed, though the ordering of bonding of the four nearest neighbours is different. (6) The binding site is five-coordinated with an apical oxygen (probably water), with more significant variability, even at 10 K – confirmed, proving that the water can oscillate in the weak apical potential; incidentally, a second apical oxygen for distorted octahedral geometry was also tested, but is not supported by the data. (7) The uncertainty estimates measured as a function of k are as measured – confirmed; they appear initially to be accurate within no worse than 50% uncertainty on the uncertainties, on the basis of the structural significance and the fitting , but the detailed analysis and suggest an accuracy of estimates better than 20%, or even with the multiple weighted fit of seven scans to be within 2%. (8) Hence the choice and number of model parameters fitted are close to a limit on the basis of the quality of these particular datasets – confirmed. (9) The site for N-truncated CuII:Aβ4–y peptide fragments is a completely different site and bonding from that of CuII:Aβ1–y peptide fragments – confirmed. (10) The is 5 to within better than 10% – confirmed. (11) The detailed data analysis with defined (measured) uncertainties as a function of k avoids significant distortions of e.g. Fig. 2 and Tables 1 and 3 compared with earlier work, even with data of limited statistical quality – confirmed, and these plots in R space are from fits solely in k space with no kn weighting, precisely because the k weighting does not apply if the uncertainties are measured or quantified. (12) It is completely possible to have detailed and accurate insight into fragile biological solutions and active sites with limited but well defined statistics down to 15 parameters, bond-length accuracies of 0.01 Å or 0.3%, shell separations of 0.018 ± 0.006 Å and a of unity (1) – confirmed. (13) This can then be used for statistical hypothesis testing of a tenth bonding parameter of a weak or blurred signature with careful F testing – confirmed. (14) To achieve this, it is recommended as necessary to use valid statistical measures of inference, even with modern caveats.
|
In the next section, we present a series of similar hypotheses for photoreduced species at room temperature in the electrochemical cell. The I in some binding sites, or Cu0 in metal form. We particularly additionally investigate the following questions. Is the photoreduced structure stable? Is it monomorphic? Is it the same binding or the same peptides? Is it four or five coordinate? Are the conclusions statistically valid?
can in principle yield Cu5. Cu reduction and CuI-binding ligands in N-truncated Aβ4–8/12/16 peptides
5.1. Identification of CuI-binding ligands from XANES
Electrochemistry drives the potential of the species to reduction or oxidation. Under reduction, any sample solution could be a mixture of CuII and CuI if the reduction has occurred during the electrolysis and if it is partial. A qualitative XANES analysis is performed to identify the CuII to CuI reduction and the involvement of residues in the peptide with the reduction process.
In this experiment, the reduction of copper ions in the peptide sample solution failed to give a current response that was distinguishable from the background signal, due to slow electron-transfer kinetics (Streltsov et al., 2018), which is consistent with the observations of Mital et al. (2015). However, perhaps surprisingly, the reduction of the sample can be recognized by significant changes in the XANES spectra.
XANES provides reliable evidence for the reduction of CuII ion into CuI ion in the N-truncated CuII:Aβ4–16 peptide. The characteristic features of CuI are obtained at potential −0.45 V versus normal hydrogen electrode. The XANES spectra of CuII:Aβ4–16/12/8 peptide complexes at the reduction potential are plotted [Figs. 6(a) and 6(b)]. The XANES series obtained at the potentials of −0.15 V, −0.25 V, −0.35 V and −0.45 V for CuII:Aβ4–16 peptide are given in Fig. 6(c). XANES-EC regions for CuII:Aβ4–12 at potentials from 0.95 to −1.20 V are given in Fig. 6(d).
Low-temperature XANES is also plotted for comparison. The characteristic CuI peak is observed at 8984 eV. The moderate changes in the potential are insensitive to the CuI spectra, justifying the reduction of CuII at room temperature. Metal-based reduction of CuII ion to CuI in both the CuII:Aβ1–16 and CuII:Aβ4–16 complexes is observed [Figs. 6(a) and 6(b)].
The findings of the current study are consistent with Kau et al. (1987) – the XANES spectra demonstrate the characteristic peak at about 8984 eV, associated with the 1s–4p transition across the range 8980–8985 eV. A similar CuI peak was reported in metal reduction of Cu:Aβ1–16/42 (Streltsov & Varghese, 2008). The pre-edge peak heights of the current CuII:Aβ1–16 spectra (Fig. 7) are slightly smaller than the reported spectra for CuII:Aβ1–16 reductions by ascorbate (Streltsov & Varghese, 2008). Hureau et al. (2009) suggest that a greater intensity obtained for the CuI pre-edge feature was due to complete reduction of CuII:Aβ. The CuI-binding geometry and linearity of the coordination are also associated with the intensity of the pre-edge peak. The linearity of two-coordinated CuI geometry would dictate the properties and productivity of redox reactions (Himes et al., 2007; Shearer & Szalai, 2008).
The XANES spectra of CuII:Aβ4–12/8 peptide at the above-mentioned potentials have insignificant changes from the low-temperature spectrum, demonstrating no of copper ion over a long period of time (ca 30 min). A further reduction of CuI to Cu0 was observed with stronger (forcing) reduction potentials. However, more careful investigations can explore the Cu0 reduction. These experimental results with different-length N-truncated Aβ prove not only the non-engagement of the ATCUN CuII-binding motif in copper-ion reduction but also the involvement of some suitable coordination for CuI to access. Requirement of more forcing conditions for the reduction of CuII:Aβ4–12/8 was observed, suggesting that the reduction of CuII in the ATCUN site is feasible at moderate potential for peptide sequences including H13H14.
An XANES-EC series of different reducing potentials from 0.05 to −0.45 V were given in Fig. 6. Past reported reducing potentials for CuII:Aβ1–y peptide complexes including CuII:Aβ1–16 were 0.28 to 0.34 V (Guilloreau et al., 2007; Jiang et al., 2007). Changes in the potentials depend upon the time spent towards equilibrium of reduced and for XAS-EC experiments. Mital et al. (2015) did not observe conventional electrochemical measurements for CuII:Aβ4–16. These XAS-EC results demonstrate the reversible reduction of CuII:Aβ4–16. This finding corroborates the reduction of CuII:Aβ4–16 with cysteine and glutathione (Santoro et al., 2017). Assuming that the same thermodynamic equilibrium constants are applied for CuI binding in both Aβ1–16 and Aβ4–16, then the ca 3000 times stronger CuII binding of Aβ4–16 in the ATCUN motif could change the reducing potential of CuII:Aβ4–16 by ca 0.21 V compared with the reducing potential of CuII:Aβ1–16. There has been a hypothesized intermediate preorganization site in Aβ4–16, which might be structurally related to the low-affinity CuII ATCUN-binding site, resulting in a current reduction rate dependent on kinetics of the preorganization (POET) mechanism (Streltsov et al., 2018). The involvement of H13H14 residues is significant for CuII:Aβ4–16, while the absence of H13H14 residues shows reduction for CuII:Aβ4–8/12 only to Cu0 under more reducing potentials.
5.2. Structure of the CuI-binding site in Aβ4–16 from room-temperature EXAFS
The pre-edge features of the XANES spectra suggest a three-coordinate geometry of the CuI binding into the N-truncated Aβ peptide. Therefore, a comparable DFT-optimized model for CuI with N2O coordination was used as the initial model for EXAFS-EC fitting. Two imidazole N atoms (ND1) in trans coordination arrangement and a carbonyl oxygen atom from His13 of backbone amide are bound to CuI.
The refined model allowed individual fitting of nine structural parameters, out to a single scattering path length up to 5 Å, with chemical-bond restraints. The independent fitting parameters were: δE0 – offset of the photoelectron overall scaling (amplitude reduction factor) S02; three independent thermal parameters for the axial water, for the nitrogen in His14 and for the oxygen in His13 ; and four independent radial-adjustment distances. Four restraint functions are included to maintain reasonable parameters for S02, and two bond-length estimates. Multiple scattering contributions up to four legs with contributions of up to 10% were included in the refinement.
The fit was performed from k = 3.5 to 10 Å−1. The best fit obtained was with a quasi-tetrahedral environment, with the fourth coordination site occupied by the oxygen atom of a water molecule, O (water), Table 3 (Fig. 8). The significance of this improvement is supported by the statistical F test: F2, 9 = 6.53 is greater than the tabulated value of F distribution, F2, 9, 0.05 = 4.26, for the significance level of α = 5%. The consistency of the refined parameters of individual scans [CuI:Aβ4–16(1) and CuI:Aβ4–16(2)] justifies the non-photoreduction of the measurements. The fitting was improved by adding the fourth coordinating oxygen atom (water) (Fig. 9).
The four-coordinate geometry with quasi-tetrahedral N2O2 centre for CuI binding in Aβ4–16 is comparable with that of the N2OS centre for transmembrane Cu transporter protein (CTR11–14) by analysis (Pushie et al., 2015). In our analysis, distances of the CuI ion to nitrogen atoms range from 1.803 (7) to 1.98 (1) Å. These findings are consistent within the returned errors with those for the CTR11–14 (Pushie et al., 2015; Streltsov et al., 2018), and are more accurate with propagated uncertainties. Other ligands available in the Aβ4–42 sequence, for example sulfur (S) in glutathione (GSH) or methionine 35 (Met35), can substitute with the O (water) in the CuI:Aβ4–16. It is widely held that Met35 in Aβ results in neurotoxic action. Misiti et al. (2010) discussed the association of Met35 with Aβ in generating ROS. Butterfield & Sultana (2011) discussed the understanding of Met35 of Aβ and its contribution of oxidative stress. There is a strong possibility that the oligomeric CuI:Aβ species with Met35 can also induce neurotoxicity in the brain. The presence of soft donor atoms in significantly affects reduction kinetics, especially in a POET mechanism where kinetics of equilibrium state happen during the reduction (Streltsov et al., 2018). Hence, the structure of the oligomers and peptide conformations are important, as the propensity to generate ROS is different.
The transfer of copper ion from the ATCUN site to the bis-His site with reduction could possibly proceed through the H6-H13/H14 intermediate site for CuII:Aβ4–16, in the same way as in the CuII:Aβ1–16 reduction process (Balland & Hureau, 2010). However, the XAS-EC results do not explain the details of the electron-transfer rate or of the intermediate-site geometry. The low-affinity intermediate CuII-binding site is available at a ratio of 1.8/1 for CuII/Aβ4–16 (Mital et al., 2015). This intermediate binding site is possibly formed by the bis-His site with an additional residue including His6 (Fig. 10). This may be assisted by forming a four-coordinated CuI-binding structure, which produced the best-fitted results and an XANES pre-edge peak at ∼8984 eV.
Conventional voltammetry experiments for CuII:Aβ4–16 returned no current response above the background (Mital et al., 2015). Kinetics of CuII:Aβ4–16 lower than CuII:Aβ1–16 explain the more negative potential and the slower electron-transfer rate resulting in indetectable voltammetry responses for CuII:Aβ4–16. The reduction rate of CuII:ATCUN depends on the barrier to equilibrium to intermediate sites (Schwab et al., 2016). Structural conformation and the length of the sequence are important for the reduction of an ion between two binding motifs separated by an amino acid for copper-bound protein complexes. This could be complicated with aggregation of metal-bound in the form of oligomers or plaques.
These results indicate that the reduction of CuII in the ATCUN site of is dependent on the availability of other accessible binding sites or ligands and dynamic stability connecting to copper binding into the sites.
XAS-EC data would expect a mixture of CuI and CuII. Therefore, linear combination analysis (LCA) was applied to the room-temperature CuI:Aβ4–16 data using the references of the low-temperature CuII:Aβ4–16 fitted data and room-temperature CuI:Aβ4–16 fitted data as the standards. The results show a CuI/CuII ratio of 0.994/0.006 in the room-temperature mixture, within one standard error of unity (see Appendix A for details).
6. CuII oxidation in N-truncated Aβ4–8/12/16 peptides
6.1. Qualitative identification of CuIII-binding ligands from XANES
We conducted an XAS-EC experiment to collect XANES spectra to investigate the occurrence of CuII to CuIII oxidation in the solution. The changes related to an oxidation process were observed in the pre-edge region at an oxidative potential of 0.95–1.35 V during XAS-EC for CuII:Aβ4–12/16. The oxidative process may be associated with the creation of CuIII (Figs. 11 and 12). Similar types of irreversible oxidation peaks were reported for CuII complexes of the terminally blocked hexapeptide TESHHK from cyclic voltammetry data at pH 11.6 (Kaczmarek et al., 2005). Generally, the presence of CuII shifts the oxidation peak to a more positive potential (Tsai & Weber, 1992).
Our XANES spectra show a small intensity increase in the pre-edge region with a slight shift at 8979.5 eV for CuII:Aβ4–12/16 [Figs. 12(b) and 12(d)]. This may illustrate the involvement of CuIII. This may also indicate any symmetry changes in the site. The small pre-edge peak at about 9879 eV could correspond with the 1s–3d electron transition in copper. A similar pre-edge peak was found at 8979.3 ± 0.3 eV for a 13-membered ring cyclic tetrapeptide c(Lys-DHis-βAla-His) (DK13)/CuIII complex structure from XANES (Pratesi et al., 2012). This supports a possible interpretation of oxidation from CuII to CuIII in Cu:Aβ4–y peptides.
No significant changes in XANES-EC were observed for CuII:Aβ4–8 at 0.85 V suggesting that the oxidation could be tyrosine centred. Tsai & Weber (1992) investigated the influence of the Tyr10 residue in CuII-peptide complexes. They illustrated the change of Cu oxidation reaction with the involvement of Tyr10, concluding that Tyr10 increases the oxidation and that the position of Tyr10 in the peptide is sensitive to the reaction.
6.2. Possible CuIII-binding site in Aβ4–16/12 from room-temperature EXAFS
The presence of CuIII oxidation states in CuIII:Aβ4–16/12 are suggested from XANES. A reliable 4N quasi-planar square structural geometry for CuIII binding in a cyclic tetrapeptide c(Lys-DHis-βAla-His) (DK13)/CuIII complex was reported from and XANES analysis (Pratesi et al., 2012). An involvement of axial hydroxide in CuIII binding leading to a stability in the coordination but a slight distortion of the Cu–N geometry was reported (Kaczmarek et al., 2005). Hence, the refined CuIIAβ4–8/12/16 model – first-shell Cu coordination in the ATCUN-binding site with an arrangement of four nitrogen ligands in equatorial positions, including the phenylalanine amino group N(Phe4); two deprotonated from the first two peptide bonds, N(Arg5) and N(His6); and an N atom of the imidazole side chain of the histidine residue, ND1(His6), with a fifth coordination oxygen along the tetragonal pyramid geometry – was initially used for CuIIIAβ data fitting. Room-temperature CuIII:Aβ measurements at oxidative potentials of 0.95 and 1.05 V were investigated.
The refined CuII:Aβ model was individually fit to four XAS-EC CuIII:Aβ4–16(1) and CuIII:Aβ4–12(1, 2, 3) datasets. Our model allowed individual fitting of 13 structural parameters including ten radial distances, the overall scaling S02, the energy-threshold offset δE0 and one independent thermal parameter for the axial water σ2, out to a single scattering path length up to 5 Å, with chemical-bond restraints. Seven restraint functions are used to maintain reasonable parameters for S02, σ2 and five bond-length estimates. Three thermal parameters for the nearest-neighbour nitrogens, for the second-, third- and outer-shell neighbours, σ2, were fixed at 0.001, 0.00105 and 0.011 Å−2, respectively. The best fit was obtained for the five-coordinate pyramidal arrangement about the CuIII atom. The improvement of the fit with the addition of an axial water molecule was confirmed by the F test. Experimentally calculated F2, 20 = 9.92 is greater than the tabulated F2, 20, 0.05 = 3.49 at the significance level of α = 5%. The results for CuIIIAβ using eFEFFit are given in Table 4.
|
Refined structural parameters from individual scans are in good agreement within the uncertainties, indicating the consistency of the sample solution throughout the measurement collection. Moreover, the consistency of the derived parameters confirms the absence of radiation damage. The refined distances of CuIII ion for the nitrogen atoms and apical water ranged from 1.84 (2) to 2.1 (1) and 2.11 (2) Å, respectively. These results are mainly consistent with Streltsov et al. (2018) and the literature, but are more robust and accurate with propagated uncertainties. Fig. 13 shows fitted measurements of the for CuIII:Aβ4–16(1) and CuIII:Aβ4–12(1, 2, 3) in k and R space.
This investigation of CuIII production corresponds to the CuII oxidation by H2O2 that leads to oxidative damage in the peptide (Kaczmarek et al., 2005; Puri & Edgerton, 2014). Tay et al. (2009) illustrated the oxidative activity of salivary copper with Hst5 Cu-metal binding. They explicitly discussed the toxicity produced by the oxidation with the presence and absence of H2O2. Rapid generation of oxidized Cu in CuII complexes with ascorbic acid and H2O2 was also reported (Burke et al., 2003). The reactivity coming from the Fenton mechanism could damage DNA. Similar toxicity could possibly be generated by the CuII oxidation in Cu:Aβ4–y The water molecule modelled in the low-temperature analysis corresponds to the further H2O2 interaction at an apical arrangement of the copper site (Tsai & Weber, 1992; Kaczmarek et al., 2005).
7. Supporting information
Detailed eFEFFit scripts are provided in the supporting information.
8. Conclusions
The XAS-EC setup is a powerful technique for collecting high-quality
measurements of biological samples under varying physical conditions. Here, the estimation of uncertainties was obtained from the point-wise variance of the spectra. Radiation damage of the sample was explicitly diagnosed and minimized through the data collection. The consistency of the repeated measurements and refined structural parameters is evidence for the minimal radiation damage. Quantitatively, no damage was observed in the optimized scans reported.Low-temperature II:Aβ4–8/12/16 illustrated identical XANES and confirming the consistency of CuII ATCUN-type binding to four N ligands located in the first three amino acids (FRH). Strong evidence of a fifth ligand in the axial position was observed, yielding a tetragonal pyramidal geometry for the binding site. Neither Tyr10 nor Glu11 contribute to the CuII binding, and therefore to identical for CuIIAβ4–8/12/16. The individual detector-pixel-based variance was used to accurately quantify the uncertainties of the fluorescence measurements. The refined structural parameters were compared by fitting the model with individual and multiple from a robust analysis using eFEFFit with propagated experimental uncertainties. The XANES and analysis strengthens the argument that the identical high-affinity ATCUN-type copper-binding site is located in N-truncated CuIIAβ isoforms detected in Alzheimer's patients' brains (Masters et al., 1985b).
measurements of N-truncated CuXAS-EC measurements at room temperature enabled us to investigate the products of the redox process and their structures. Previously reported electrochemical measurements (Mital et al., 2015) were incapable of demonstrating any response different from the background for CuII:Aβ4–16 reduction chemistry, but our XAS-EC measurements provided the reduction details, which are similar to the reduced product of CuII:Aβ1–16, at relatively mild potentials. Identification of reduction chemistry for CuII:Aβ4–8/12 clearly proves the benefits of XAS-EC experiments for with slow electron-transfer rates. The reduced CuI ion in Cu:Aβ4–16 binds to the bis-His site in a quasi-tetrahedral environment geometry. The results and observations of this experiment illustrate that the CuII and CuI redox chemistry of Cu:Aβ4–16 was driven by a combination of kinetics and thermodynamic effects through the POET reaction pathways explained for CuII:Aβ1–16 (Balland & Hureau, 2010; Streltsov et al., 2018). N-truncated Aβ have a strong CuII binding into the high-affinity ATCUN-binding site. However, if a copper ion can access an intermediate-site geometry within the peptide, then, the redox reactions of the copper ion will still feasible. Therefore, the involvement of H13H14 is essential for the CuII:Aβ complexes. Generation of ROS for N-truncated Aβ is different from full-length Aβ due to variations in the kinetics of to binding sites. However, involvement of residues through the intermediate sites may precede redox activities in CuII:Aβ complexes. A comprehensive study of intermediate-site structure during reductions can be performed using XAS-EC and the high-energy fluorescence detection (Shearer & Szalai, 2008; Arrigoni et al., 2018; Falcone et al., 2023) approach in future.
XANES features of the oxidative product were observed and structural parameters consistent with crystallographic data were achieved from II and CuIII states bound to a five-coordination ATCUN-type copper-binding site including an axial oxygen from a water molecule exit in oxidation of CuII:Aβ4–12/16 complexes. The redox process includes the CuII catalyzed oxidation of residues. The current analysis does not reveal the redox state of ligands not bound to Cu. Further investigations can be conducted for different Cu:Aβ sequences to explore redox behaviour and potential structural dependence.
analysis. CuLiterature reports the evidence of using N-truncated Aβ resonant for better drug targets in the brain than full-length Aβ (Bayer & Wirths, 2016). A comprehensive knowledge of the redox behaviour and atomic structure of Cu-bound N-truncated Aβ complexes would be beneficial in developing Aβ-related therapies and diagnostic processes, and identifying the functionality of different Aβ sequences. A similar behaviour of ATCUN-bound CuII:Aβ4–y was observed in transmembrane Cu transport protein (CTR1). High-affinity ATCUN-bound complexes including the bis-His binding motif (oligomers Aβ4–y) are separated in CTR1, allowing CuII reduction to CuI, which follows further chemistry of generating ROS. Monomeric Aβ4–y acts as an associate for CTR1 to transfer copper.
Moreover, the determined structural and chemical properties of Cu:Aβ4–y are comparable to functions of AMPs such as Hst5 including ATCUN and the bis-His motif. AMPs follow mechanisms of intracellular killing resulting in the inhibition of mitochondrial respiration, possibly via ROS and oxidation stress produced locally and temporarily (Kaczmarek et al., 2005). Hst5 with copper in ascorbic reductant produces noticeable amounts of hydrogen peroxide, H2O2 (Houghton & Nicholas, 2009). Redox reactions of CuII complexes with an ATCUN site (Pratesi et al., 2012; Jin & Cowan, 2005) provide details of generating hydroxyl-like radicals and associate with the production of complexes accommodating CuIII in a vigorous oxidative environment. N-truncated Cu:Aβ4–y consists of an ATCUN-binding site and may have a similar Hst5-type mechanism of antimicrobial activity and perform as an effector molecule in the innate immune system. This could be a supplementary function of antimicrobial activity to form transmembrane pore and membrane binding (Brogden, 2005; Soscia et al., 2010).
Overall, our experiments illustrate that M) under an electrochemical environment. The quality of measurements is sufficient for structural analysis. Moreover, the current work demonstrates insight into the redox-reaction paths achieved from XAS-EC and the possibility of accommodating unstable coordinating sites in catalytic reactions of These experiments reveal a profound form of redox behaviour that is important in the chemistry of Cu:Aβ aggregates. This leads to a final question (hypothesis?): is it necessary for the development of Alzheimer's dementia to have N-truncated Aβ4–y peptide fragments in the brain, rather than the more weakly binding and less reactive Aβ1–y peptide fragments or the largely inactive Aβ1–42 peptide possibly leading to the plaque? Furthermore, is it also necessary for the development of Alzheimer's dementia to have peptide fragments in the brain with y > 16 (these exist) so that reactive oxidation damage can occur?
can characterize the electronic and molecular structure of an absorber in a biological metalloprotein sequence with accurate experimental measurements and propagated experimental uncertainties. As mentioned above, the experimental uncertainties of the measurements were obtained from the point-wise variance of the spectra. Standard errors of fluorescence measurements were used as uncertainties for fitting. Use of calculated uncertainties rather than using an estimated uncertainty enables a reliable quantification for the structural refinements of sample fits. The current work determined uncertainties in analysis software packages for structural fitting. The structural information of N-truncated is sufficient to understand their metal chemistry. This work demonstrates the process of collecting measurements of metalloprotein samples of smaller quantities (<1 ml, 1 mAPPENDIX A
Linear combination analysis for calculation of CuI:CuII ratio in room-temperature data
LCA was performed to explore if room-temperature I and CuII. The LCA standards included refined CuI:Aβ4–16 room-temperature data and refined CuII:Aβ4–16 low-temperature data. Experimentally collected Cu:Aβ4–16 XAS-EC data were fitted as
data could be identified as a mixture of Cuwhere A is the percentage contribution of CuI in the hypothesized mixture. This LCA is based on the k space from 3.5 to 10 Å−1. The fitting returned a CuI:CuII ratio of 0.994:0.006 in the room-temperature mixture (Fig. 14). No significant CuII contamination exists in the room-temperature mixture, especially given the 1.44% uncertainty of the LCA ratio. The standards used here are from the experiments at different conditions (CuII:Aβ4–16 different temperatures and under no voltage). The LCA can be further investigated by conducting further experiments. Whilst this LCA is not foolproof, it is strongly suggestive of complete reduction.
Streltsov et al. (2008) performed linear combination fitting (LCF) to CuI:Aβ4–16 XAS-EC data using the ATHENA package. They found a CuI:CuII ratio of 97:3%. However, the analysis was conducted using previous unpublished CuI:Aβ1–16 data as the standard. We anticipate that it would have be more transparent if the experimental data under similar conditions had been used for the LCF. Our standards have these similar experimental conditions and therefore our CuI:CuII ratio is more reliable.
Supporting information
Script to run eFEFFIT for the Cu(I)-binding model. DOI: https://doi.org/10.1107/S2052252524001830/oz5005sup1.txt
Script to run eFEFFIT for the Cu(II)-binding model. DOI: https://doi.org/10.1107/S2052252524001830/oz5005sup2.txt
The low-temperature (5K-10K) dead-time corrected, defective-pixel corrected and normalized for dispersion I_f/I_0 measurements of Cu(II):amyloid-beta(4-12/8), and their uncertainties for mu2chi. DOI: https://doi.org/10.1107/S2052252524001830/oz5005sup3.txt
The low-temperature dead-time corrected, defective-pixel corrected and normalized for dispersion I_f/I_0 measurements of Cu(II):amyloid-beta(4-16), and their uncertainties for mu2chi. DOI: https://doi.org/10.1107/S2052252524001830/oz5005sup4.txt
The room-temperature dead-time corrected, defective-pixel corrected and normalized for dispersion I_f/I_0 measurements of Cu(I):amyloid-beta(4-16), and their uncertainties for mu2chi. DOI: https://doi.org/10.1107/S2052252524001830/oz5005sup5.txt
The room-temperature dead-time corrected, defective-pixel corrected and normalized for dispersion I_f/I_0 measurements of N-truncated Cu(III):amyloid-beta https://doi.org/10.1107/S2052252524001830/oz5005sup6.txt
DOI:Acknowledgements
We sincerely acknowledge and thank Simon C. Drew and Mariuz Mital for their contributions here and in sample preparation. Part of this research was undertaken on the
beamline at the Australian Synchrotron, ANSTO. We thank ANSTO and the Australian Synchrotron for their efforts and dedication to build up part of this methodology. We thank all of the synchrotron team including Peter Kappen, Bernt Johannessen, Jeremy Wykes, Chris Glover and Susan Cumberland for their support and dedication during the data collection.Funding information
We are grateful for The Laby Foundation scholarship awarded by the School of Physics, University of Melbourne for supporting this research.
References
Abelein, A., Ciofi-Baffoni, S., Kumar, R., Giachetti, A., Piccioli, M. & Biverstal, H. (2022). J. Am. Chem. Soc. 2, 2571–2584. CAS Google Scholar
Ankudinov, A. L., Nesvizhskii, A. I. & Rehr, J. J. (2003). Phys. Rev. B, 67, 115120. Web of Science CrossRef Google Scholar
Arrigoni, F., Prosdocimi, T., Mollica, L., De Gioia, L., Zampella, G. & Bertini, L. (2018). Metallomics, 10, 1618–1630. Web of Science CrossRef CAS PubMed Google Scholar
Balland, V., Hureau, C. & Savéant, J. M. (2010). Proc. Natl Acad. Sci. USA, 107, 17113–17118. Web of Science CrossRef CAS PubMed Google Scholar
Barnham, K. J., Masters, C. L. & Bush, A. I. (2004). Nat. Rev. 3, 205–214. CAS Google Scholar
Bayer, T. A. & Wirths, O. (2016). Immunotherapy and Biomarkers in Neurodegenerative Disorders, edited by M. Ingelsson & L. Lannfelt, pp. 37–50. New York: Springer. Google Scholar
Best, S. P. & Chantler, C. T. (2022). In International Tables for Crystallography, Vol. I, edited by C. T. Chantler, F. Boscherini & B. Bunker. IUCr/Wiley. Google Scholar
Best, S. P., Levina, A., Glover, C., Johannessen, B., Kappen, P. & Lay, P. A. (2016). J. Synchrotron Rad. 23, 743–750. Web of Science CrossRef CAS IUCr Journals Google Scholar
Binsted, N., Strange, R. W. & Hasnain, S. S. (1992). Biochemistry, 31, 12117–12125. CrossRef PubMed CAS Web of Science Google Scholar
Bossak-Ahmad, K., Mital, M., Płonka, D., Drew, S. C. & Bal, W. (2019). Inorg. Chem. 58, 932–943. Web of Science CAS PubMed Google Scholar
Brogden, K. A. (2005). J. Am. Chem. Soc. 3, 238–250. CAS Google Scholar
Burke, S. K., Xu, Y. & Margerum, D. W. (2003). Inorg. Chem. 42, 5807–5817. Web of Science CrossRef PubMed CAS Google Scholar
Butterfield, D. A. & Sultana, R. (2011). J. Amino Acids, 2011, 198430. Google Scholar
Cabrera, E., Mathews, P., Mezhericher, E., Beach, T. G., Deng, J., Neubert, T. A., Rostagno, A. & Ghiso, J. (2018). Biochim. Biophys. Acta, 1864, 208–225. Web of Science CrossRef CAS Google Scholar
Camerman, N., Camerman, A. & Sarkar, B. (1976). Can. J. Chem. 54, 1309–1316. CSD CrossRef CAS Web of Science Google Scholar
Chantler, C. T. (2009). Eur. Phys. J. Spec. Top. 169, 147–153. Web of Science CrossRef Google Scholar
Chantler, C. T. (2022). In International Tables for Crystallography, Vol. I, edited by C. T. Chantler, F. Boscherini & B. Bunker. IUCr/Wiley. Google Scholar
Chantler, C. T., Barnea, Z., Tran, C. Q., Rae, N. A. & de Jonge, M. D. (2012). J. Synchrotron Rad. 19, 851–862. Web of Science CrossRef CAS IUCr Journals Google Scholar
Chantler, C. T., Barnea, Z., Tran, C. Q., Tiller, J. B. & Paterson, D. (1999). Opt. Quantum Electron. 31, 495–505. Web of Science CrossRef CAS Google Scholar
Chantler, C. T., Tran, C. Q., Paterson, D., Cookson, D. & Barnea, Z. (2001). Phys. Lett. A, 286, 338–346. Web of Science CrossRef CAS Google Scholar
Cheignon, C., Jones, M., Atrián-Blasco, E., Kieffer, I., Faller, P., Collin, F. & Hureau, C. (2017). Chem. Sci. 8, 5107–5118. Web of Science CrossRef CAS PubMed Google Scholar
Cheignon, C., Tomas, M., Bonnefont-Rousselot, D., Faller, P., Hureau, C. & Collin, F. (2018). Redox Biology, 14, 450–464. Web of Science CrossRef CAS PubMed Google Scholar
Curtain, C. C., Ali, F., Volitakis, I., Cherny, R. A., Norton, R. S., Beyreuther, K., Barrow, C. J., Masters, C. L., Bush, A. I. & Barnham, K. J. (2001). J. Biol. Chem. 276, 20466–20473. Web of Science CrossRef PubMed CAS Google Scholar
Dietrich, K., Bouter, Y., Müller, M. & Bayer, T. A. (2018). Molecules, 23, 718. Web of Science CrossRef PubMed Google Scholar
Dimakis, N. & Bunker, G. (2002). Phys. Rev. B, 65, 201103. Web of Science CrossRef Google Scholar
Drew, S. C. (2017). Front. Neurosci. 11, 317. Web of Science CrossRef PubMed Google Scholar
Drew, S. C., Masters, C. L. & Barnham, K. J. (2009a). J. Am. Chem. Soc. 131, 8760–8761. Web of Science CrossRef PubMed CAS Google Scholar
Drew, S. C., Noble, C. J., Masters, C. L., Hanson, G. R. & Barnham, K. J. (2009b). J. Am. Chem. Soc. 131, 1195–1207. Web of Science CrossRef PubMed CAS Google Scholar
Dunys, J., Valverde, A. & Checler, F. (2018). J. Biol. Chem. 293, 15419–15428. Web of Science CrossRef CAS PubMed Google Scholar
Ekanayake, R. S. K., Chantler, C. T., Sier, D., Schalken, M. J., Illig, A. J., de Jonge, M. D., Johannessen, B., Kappen, P. & Tran, C. Q. (2021). J. Synchrotron Rad. 28, 1492–1503. Web of Science CrossRef CAS IUCr Journals Google Scholar
Ekanayake, R. S. K., Streltsov, V. A., Best, S. P. & Chantler, C. T. (2024). J. Appl. Cryst. 57, 125–139. CrossRef CAS IUCr Journals Google Scholar
Ellis, P. J. & Freeman, H. C. (1995). J. Synchrotron Rad. 2, 190–195. CrossRef CAS Web of Science IUCr Journals Google Scholar
Esmieu, C., Ferrand, G., Borghesani, V. & Hureau, C. (2021). Chem. A Eur. J. 27, 1777–1786. Web of Science CrossRef CAS Google Scholar
Falcone, E., Nobili, G., Okafor, M., Proux, O., Rossi, G., Morante, S., Faller, P. & Stellato, F. (2023). Angew. Chem. Int. Ed. 62, e202217791. Web of Science CrossRef Google Scholar
Faller, P. & Hureau, C. (2009). Dalton Trans. pp. 1080–1094. Web of Science CrossRef Google Scholar
Filipponi, A. (1995). Phys. Rev. B, 7, 9343–9356. CAS Google Scholar
Filipponi, A. & Di Cicco, A. (1995). Phys. Rev. B, 52, 15135–15149. CrossRef CAS Web of Science Google Scholar
Furlan, S., Hureau, C., Faller, P. & La Penna, G. (2010). J. Phys. Chem. B, 114, 15119–15133. Web of Science CrossRef CAS PubMed Google Scholar
Ganguly, G., Chakrabarti, S., Chatterjee, U. & Saso, L. (2017). Drug Des. Dev. Ther. 11, 797–810. Web of Science CrossRef CAS Google Scholar
Guilloreau, L., Combalbert, S., Sournia–Saquet, A., Mazarguil, H. & Faller, P. (2007). ChemBioChem, 8, 1317–1325. Web of Science CrossRef PubMed CAS Google Scholar
Harford, C. & Sarkar, B. (1997). Acc. Chem. Res. 30, 123–130. CrossRef CAS Web of Science Google Scholar
Himes, R. A., Park, G. Y., Barry, A. N., Blackburn, N. J. & Karlin, K. D. (2007). J. Am. Chem. Soc. 129, 5352–5353. Web of Science CrossRef PubMed CAS Google Scholar
Himes, R. A., Park, G. Y., Siluvai, G. S., Blackburn, N. J. & Karlin, K. D. (2008). Angew. Chem. Int. Ed. 47, 9084–9087. Web of Science CrossRef CAS Google Scholar
Holtzman, D., Morris, J. & Goate, A. (2011). Sci. Transl. Med. 3, p. 77sr1. Google Scholar
Houghton, E. A. & Nicholas, K. M. (2009). J. Biol. Inorg. Chem. 14, 243–251. Web of Science CrossRef PubMed CAS Google Scholar
Huang, X. D., Cuajungco, M. P., Atwood, C. S., Hartshorn, M. A., Tyndall, J. D. A., Hanson, G. R., Stokes, K. C., Leopold, M., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Saunders, A. J., Lim, J., Moir, R. D., Glabe, C., Bowden, E. F., Masters, C. L., Fairlie, D. P., Tanzi, R. E. & Bush, A. I. (1999). J. Biol. Chem. 274, 37111–37116. Web of Science CrossRef PubMed CAS Google Scholar
Hureau, C. (2012). Mol. Brain, 256, 2164–2174. CAS Google Scholar
Hureau, C., Balland, V., Coppel, Y., Solari, P. L., Fonda, E. & Faller, P. (2009). J. Biol. Inorg. Chem. 14, 995–1000. Web of Science CrossRef PubMed CAS Google Scholar
Hureau, C., Eury, H., Guillot, R., Bijani, C., Sayen, S., Solari, P. L., Guillon, E., Faller, P. & Dorlet, P. (2011). Chem. Eur. J. 17, 10151–10160. Web of Science CSD CrossRef CAS PubMed Google Scholar
Jiang, D., Men, L., Wang, J., Zhang, Y., Chickenyen, S., Wang, Y. & Zhou, F. (2007). Biochemistry, 46, 9270–9282. Web of Science CrossRef PubMed CAS Google Scholar
Jin, Y. & Cowan, J. A. (2005). J. Am. Chem. Soc. 127, 8408–8415. Web of Science CrossRef PubMed CAS Google Scholar
John, M. W., Sier, D., Ekanayake, R. S. K., Schalken, M. J., Tran, C. Q., Johannessen, B., de Jonge, M. D., Kappen, P. & Chantler, C. T. (2023). J. Synchrotron Rad. 30, 147–168. Web of Science CrossRef CAS IUCr Journals Google Scholar
Kaczmarek, P., Jeżowska-Bojczuk, M., Gatner, K. & Bal, W. (2005). Dalton Trans. pp. 1985. Google Scholar
Karr, J. W., Akintoye, H., Kaupp, L. J. & Szalai, V. A. (2005). Biochemistry, 44, 5478–5487. Web of Science CrossRef PubMed CAS Google Scholar
Kau, L. S., Spira-Solomon, D. J., Penner-Hahn, J. E., Hodgson, K. O. & Solomon, E. I. (1987). J. Am. Chem. Soc. 109, 6433–6442. CrossRef CAS Web of Science Google Scholar
Levina, A., Armstrong, R. S. & Lay, P. A. (2005). Coord. Chem. Rev. 249, 141–160. Web of Science CrossRef CAS Google Scholar
Masters, C. L., Multhaup, G., Simms, G., Pottgiesser, J., Martins, R. N. & Beyreuther, K. (1985a). EMBO J. 4, 2757–2763. CrossRef CAS PubMed Web of Science Google Scholar
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L. & Beyreuther, K. (1985b). Proc. Natl Acad. Sci. USA, 82, 4245–4249. CrossRef CAS PubMed Web of Science Google Scholar
McLean, C. A., Cherny, R. A., Fraser, F. W., Fuller, S. J., Smith, M. J., Vbeyreuther, K., Bush, A. I. & Masters, C. L. (1999). Ann. Neurol. 46, 860–866. Web of Science CrossRef PubMed CAS Google Scholar
Minicozzi, V., Stellato, F., Comai, M., Dalla Serra, M., Potrich, C., Meyer-Klaucke, W. & Morante, S. (2008). J. Biol. Chem. 283, 10784–10792. Web of Science CrossRef PubMed CAS Google Scholar
Misiti, F., Clementi, M. E. & Giardina, B. (2010). Neurochem. Int. 56, 597–602. Web of Science CrossRef CAS PubMed Google Scholar
Mital, M., Wezynfeld, N. E., Frączyk, T., Wiloch, M. Z., Wawrzyniak, U. E., Bonna, A., Tumpach, C., Barnham, K. J., Haigh, C. L., Bal, W. & Drew, S. C. (2015). Angew. Chem. Int. Ed. 54, 10460–10464. Web of Science CrossRef CAS Google Scholar
Morante, S. (2008). Curr. Alzheimer Res. 5, 508–524. Web of Science CrossRef PubMed CAS Google Scholar
O'Day, P. A., Rehr, J. J., Zabinsky, S. I. & Brown, G. E. J. (1994). J. Am. Chem. Soc. 116, 2938–2949. CAS Google Scholar
Pike, C. J., Overman, M. J. & Cotman, C. W. (1995). J. Biol. Chem. 270, 23895–23898. CrossRef CAS PubMed Web of Science Google Scholar
Poiarkova, A. V. & Rehr, J. J. (1999). Phys. Rev. B, 59, 948–957. Web of Science CrossRef CAS Google Scholar
Pratesi, A., Giuli, G., Cicconi, M. R., Della Longa, S., Weng, T. C. & Ginanneschi, M. (2012). Inorg. Chem. 51, 7969–7976. Web of Science CrossRef CAS PubMed Google Scholar
Puri, S. & Edgerton, M. (2014). Eukaryot. Cell, 13, 958–964. Web of Science CrossRef PubMed Google Scholar
Pushie, M. J., Shaw, K., Franz, K. J., Shearer, J. & Haas, K. L. (2015). Inorg. Chem. 54, 8544–8551. Web of Science CrossRef CAS PubMed Google Scholar
Raffa, D. F., Rickard, G. A. & Rauk, A. (2007). J. Biol. Inorg. Chem. 12, 147–164. Web of Science CrossRef PubMed CAS Google Scholar
Ressler, T., Brock, S. L., Wong, J. & Suib, S. L. (1999). J. Phys. Chem. B, 103, 6407–6420. Web of Science CrossRef CAS Google Scholar
Sano, M., Komorita, S. & Yamatera, H. (1992). Inorg. Chem. 31, 459–463. CrossRef CAS Web of Science Google Scholar
Santoro, A., Ewa Wezynfeld, N., Vašák, M., Bal, W. & Faller, P. (2017). Chem. Commun. 53, 11634–11637. Web of Science CrossRef CAS Google Scholar
Schalken, M. J. & Chantler, C. T. (2018). J. Synchrotron Rad. 25, 920–934. Web of Science CrossRef CAS IUCr Journals Google Scholar
Schwab, S., Shearer, J., Conklin, S. E., Alies, B. & Haas, K. L. (2016). J. Inorg. Biochem. 158, 70–76. Web of Science CrossRef CAS PubMed Google Scholar
Shearer, J., Callan, P. E., Tran, T. & Szalai, V. A. (2010). Chem. Commun. 46, 9137–9139. Web of Science CrossRef CAS Google Scholar
Shearer, J. & Szalai, V. A. (2008). J. Am. Chem. Soc. 130, 17826–17835. Web of Science CrossRef PubMed CAS Google Scholar
Shearer, W. T., Bradshaw, R. A., Gurd, F. R. & Theodore, P. Jr (1967). J. Biol. Chem. 242, 5451–5459. CrossRef PubMed CAS Google Scholar
Sier, D., Cousland, G. P., Trevorah, R. M., Ekanayake, R. S. K., Tran, C. Q., Hester, J. R. & Chantler, C. T. (2020). J. Synchrotron Rad. 27, 1262–1277. Web of Science CrossRef CAS IUCr Journals Google Scholar
Smale, L. F., Chantler, C. T., de Jonge, M. D., Barnea, Z. & Tran, C. Q. (2006). Radiat. Phys. Chem. 75, 1559–1563. Web of Science CrossRef CAS Google Scholar
Smith, M. A., Nunomura, A., Zhu, X., Takeda, A. & Perry, G. (2000). Antioxid. Redox Signal. 2, 413–420. Web of Science CrossRef PubMed CAS Google Scholar
Soscia, S. J., Kirby, J. E., Washicosky, K. J., Tucker, S. M., Ingelsson, M., Hyman, B., Burton, M. A., Goldstein, L. E., Duong, S., Tanzi, R. E. & Moir, R. D. (2010). PLoS One, 5, e9505. Web of Science CrossRef PubMed Google Scholar
Sóvágó, I. & Ősz, K. (2006). Dalton Trans. pp. 3841–3854. Google Scholar
Stellato, F., Menestrina, G., Serra, M. D., Potrich, C., Tomazzolli, R., Meyer-Klaucke, W. & Morante, S. (2006). Eur. Biophys. J. 35, 340–351. Web of Science CrossRef PubMed CAS Google Scholar
Strange, R. W., Alagna, L., Durham, P. & Hasnain, S. S. (1990). J. Am. Chem. Soc. 112, 4265–4268. CrossRef CAS Web of Science Google Scholar
Streltsov, V. A., Ekanayake, R. S. K., Drew, S. C., Chantler, C. T. & Best, S. P. (2018). Inorg. Chem. 57, 11422–11435. Web of Science CrossRef CAS PubMed Google Scholar
Streltsov, V. A. & Varghese, J. N. (2008). Chem. Commun. pp. 3169. Google Scholar
Streltsov, V., Titmuss, S., Epa, V., Barnham, K., Masters, C. & Varghese, J. (2008). Biophys. J. 95, 3447–3456. Web of Science CrossRef PubMed CAS Google Scholar
Summers, K. L., Schilling, K. M., Roseman, G., Markham, K. A., Dolgova, N. V., Kroll, T., Sokaras, D., Millhauser, G. L., Pickering, I. J. & George, G. N. (2019). Inorg. Chem. 58, 6294–6311. Web of Science CrossRef CAS PubMed Google Scholar
Tay, W. M., Hanafy, A. I., Angerhofer, A. & Ming, L. J. A. (2009). Bioorg. Med. Chem. Lett. 19, 6709–6712. Web of Science CrossRef PubMed CAS Google Scholar
Trevorah, R. M., Chantler, C. T. & Schalken, M. J. (2019). IUCrJ, 6, 586–602. Web of Science CrossRef CAS PubMed IUCr Journals Google Scholar
Trevorah, R. M., Chantler, C. T. & Schalken, M. J. (2020). J. Phys. Chem. A, 124, 1634–1647. Web of Science CrossRef CAS PubMed Google Scholar
Tsai, H. & Weber, S. G. (1992). Anal. Chem. 64, 2897–2903. CrossRef PubMed CAS Web of Science Google Scholar
Wang, D. M. & Hanson, G. R. (1995). J. Magn. Reson. A, 117, 1–8. CrossRef CAS Google Scholar
Wiloch, M. Z., Wawrzyniak, U. E., Ufnalska, I., Bonna, A., Bal, W., Drew, S. C. & Wróblewski, W. (2016). J. Electrochem. Soc. 163, G196–G199. Web of Science CrossRef CAS Google Scholar
Yu, H., Ren, J. & Qu, X. (2008). ChemBioChem, 9, 879–882. Web of Science CrossRef PubMed CAS Google Scholar
Zabinsky, S. I., Rehr, J. J., Ankudinov, A., Albers, R. C. & Eller, M. J. (1995). Phys. Rev. B, 52, 2995–3009. CrossRef CAS Web of Science Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.